Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women.

Background: Myeloperoxidase (MPO) is an enzyme involved in the pathogenesis of several diseases.

Aim: The current study aimed to investigate serum MPO levels in obese Egyptian women and assess its relation with insulin resistance (IR) and other biochemical risk parameters.

Methods: The study included 80 obese women and 50 age-and-sex-matched healthy controls.

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women.

Obesity is one of the diagnostic criteria of metabolic syndrome (MS). It is correlated with insulin resistance (IR) and high vascular risk as well. Advanced glycation end products (AGEs) and their receptor (RAGE) play an important role in abnormal metabolic components in obese women.